Personalized Health Care Holding AG in Liquidation
Company Overview
Previous Company Names
- Alphaptosis Group IP AG
- (Alphaptosis Group IP Ltd) (Alphaptosis Group IP SA)
- Personalized Health Care Holding AG
- (Personalized Health Care Holding SA) (Personalized Health Care Holding Ltd)
Management
Marian Müller-Wolf
New York, US
Vice-chairperson of the board
Individual signing authority
Dr. Müller-Wolf
Hamburg, DE
Chairperson of the board
Individual signing authority
Roland Eisert
Baar
Manager
Individual signing authority
Dr. Alexander Vogel
Baar
Member of the board
Individual signing authority
Benno Zehnder
Remetschwil
Member of the board
Joint signing authority (any two to sign)
Roland Erlbacher
Aarburg
Member of the board
Joint signing authority (any two to sign)
Martin Müller-Wolf
Zug
Chairperson of the board
Individual signing authority
Martin Müller-Wolf
Cham
Chairperson of the board
Individual signing authority
Christiane Müller-Wolf
Nordhorn, DE
Member of the board
Individual signing authority
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 6528 | 31.03.2026 | 1006616917 | 07.04.2026 | 1006616917 |
| 2 | 3430 | 26.02.2024 | 1005973769 | 29.02.2024 | 1005973769 |
| 3 | B16365 | 12.10.2023 | 1005862359 | 17.10.2023 | 1005862359 |
| 4 | 15195 | 22.09.2023 | 1005846739 | 27.09.2023 | 1005846739 |
| 5 | 4809 | 28.03.2023 | 1005714187 | 31.03.2023 | 1005714187 |
| 6 | 4660 | 24.03.2023 | 1005711967 | 29.03.2023 | 1005711967 |
| 7 | 462 | 09.01.2023 | 1005650661 | 12.01.2023 | 1005650661 |
| 8 | 16711 | 09.11.2022 | 1005603337 | 14.11.2022 | 1005603337 |
| 9 | 4462 | 22.03.2022 | 1005435591 | 25.03.2022 | 1005435591 |
| 10 | 14815 | 28.07.2021 | 1005262594 | 02.08.2021 | 1005262594 |
Company Purpose
Erwerb, Verkauf, Halten und Verwalten von Beteiligungen an anderen Gesellschaften, insbesondere von Gesellschaften mit Tätigkeitsgebiet in der Optimierung der Unternehmensentwicklung, in der Optimierung des Gesundheitswesens sowie in der Forschung, Entwicklung und Verwertung von pharmazeutischen Wirkstoffen; vollständige Zweckumschreibung gemäss Statuten